Author:
Zhou Yiqiang,Jin Guishan,Mi Ruifang,Zhang Junwen,Zhang Jin,Xu Hengzhou,Cheng Sen,Zhang Yunsheng,Song Wenjie,Liu Fusheng
Funder
Beijing Municipal Administration of Hospitals Youth Program
National Natural Science Foundation of China
Beijing Municipal Natural Science Foundation
Beijing Health System High-level Personnel Building Foundation
Beijing Laboratory of Biomedical Materials Foundation
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference35 articles.
1. Alli PM, Pinn ML, Jaffee EM, McFadden JM, Kuhajda FP (2005) Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice. Oncogene 24:39–46. doi: 10.1038/sj.onc.1208174
2. Bian Y, Yu Y, Wang S, Li L (2015) Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer. Biochem Biophys Res Commun 463:612–617. doi: 10.1016/j.bbrc.2015.05.108
3. Bottini A, Berruti A, Bersiga A, Brizzi MP, Allevi G, Bolsi G, Aguggini S, Brunelli A, Betri E, Generali D, Scaratti L, Bertoli G, Alquati P, Dogliotti L (2002) Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. Clin Cancer Res 8:1816–1821
4. Browne CD, Hindmarsh EJ, Smith JW (2006) Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor. FASEB J 20:2027–2035. doi: 10.1096/fj.05-5404com
5. Camassei FD, Cozza R, Acquaviva A, Jenkner A, Rava L, Gareri R, Donfrancesco A, Bosman C, Vadala P, Hadjistilianou T, Boldrini R (2003) Expression of the lipogenic enzyme fatty acid synthase (FAS) in retinoblastoma and its correlation with tumor aggressiveness. Invest Ophthalmol Vis Sci 44:2399–2403. doi: 10.1002/mpo.10274
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献